ESTRO Brachytherapy for Prostate Cancer 2018

Which of the following is a contraindication to HDR brachytherapy boost

A. Multifocal prostate cancer B. PSA>20ng/ml C. Prostate volume >70ml D. Gleason score 9 E. Maximum flow rate <10ml/min

www.responseware.eu - Session ID: BT2018